《新股消息》京東健康(06618.HK)公開超購近421倍 一手中籤率40%
由京東(09618.HK)分拆的京東健康(06618.HK)公布招股結果,每股發售價定於70.58元,為上限定價(原每股招股價介乎62.8至70.58元),公開發售錄超購420.91倍,經重新分配後,公開發售股數增至11%。國際發售項已獲大幅超額認購,相當於相關初步可供認購發售股份總數約31.1倍。
一手50股中籤率為40%,抽200手方穩獲一手。該股將於明日(8日)掛牌上市,聯席保薦人為美銀、海通國際及瑞銀。
公司預計所得款項淨額約為264.57億元,約40%用於在未來36至60個月業務擴張;約30%用於在未來24至36個月研發;約20%用於潛在投資及收購或成立戰略聯盟;餘下約10%為一般營運資金。
是次招股將引入Hillhouse、Tiger Global、Lake Bleu Prime、中國國有企業結構調整基金、新加坡政府投資公司GIC及貝萊德為基石投資者,共認購1.48億股股份,佔緊隨全球發售完成後公司已發行股本共4.74%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.